Case number 1:20-cv-01502
Otsuka Pharmaceutical Co. Ltd. et al v. Prinston Pharmaceutical Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 4, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Shashank D. Upadhye for Prinston Pharmaceutical Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Mar 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (13 in 1:20-cv-01502-LPS, 63 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Prinston Pharmaceutical). Signed by Judge Leonard P. Stark on 3/9/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01502-LPS (ntl) |
| Mar 9, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl) |
| Mar 5, 2021 | 13 | Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Prinston Pharmaceutical), by H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) |
| Feb 16, 2021 | 12 | Answer to Counterclaim (5) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd..(Mayo, Andrew) |
| Feb 5, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Yixin H. Tang for Prinston Pharmaceutical Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 3, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, and Brent Batzer filed by Prinston Pharmaceutical Inc. Signed by Judge Leonard P. Stark on 2/3/21. (ntl) |
| Feb 2, 2021 | 11 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, and Brent Batzer - filed by Prinston Pharmaceutical Inc.. (Stamoulis, Stamatios) |
| Jan 26, 2021 | 10 | Answer to Complaint (21) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by Zhejiang Huahai Pharmaceutical Co., Ltd., Prinston Pharmaceutical Inc., Solco Healthcare US, LLC.(Stamoulis, Stamatios) |
| Jan 14, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Denise Main, Erin M. Sommers, C. Collette Corser, Tyler B. Latcham for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01287-LPS et al.(kmd) |
| Jan 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION Regarding Waiver of Service and Establishment of Answer Deadline for Defendant Prinston Pharmaceutical Inc. Signed by Judge Leonard P. Stark on 1/7/21. (ntl) |
| Jan 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] STIPULATION Regarding Dismissal Without Prejudice of Defendants Zhejiang Huahai Pharmaceutical Co., Ltd. and Solco Healthcare US, LLC, and Amendment of Case Caption -- Party Solco Healthcare US, LLC and Zhejiang Huahai Pharmaceutical Co., Ltd. terminated. Signed by Judge Leonard P. Stark on 1/7/21. (ntl) |
| Jan 6, 2021 | 8 | Stipulation (5) Docket Text: STIPULATION Regarding Dismissal Without Prejudice of Defendants Zhejiang Huahai Pharmaceutical Co., Ltd. and Solco Healthcare US, LLC, and Amendment of Case Caption, by H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd.. (Balick, Steven) |
| Jan 6, 2021 | 9 | Stipulation (2) Docket Text: STIPULATION Regarding Waiver of Service and Establishment of Answer Deadline for Defendant Prinston Pharmaceutical Inc., by H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd.. (Balick, Steven) |
| Jan 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:20-cv-01365-LPS, 8 in 1:20-cv-01287-LPS, 13 in 1:20-cv-01296-LPS, 9 in 1:20-cv-01599-LPS, 7 in 1:20-cv-01428-LPS, 12 in 1:20-cv-01423-LPS, 11 in 1:20-cv-01335-LPS, 10 in 1:20-cv-01295-LPS, 7 in 1:20-cv-01581-LPS, 7 in 1:20-cv-01502-LPS, 7 in 1:20-cv-01763-LPS, 10 in 1:20-cv-01297-LPS, 11 in 1:20-cv-01332-LPS, 13 in 1:20-cv-01531-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01287-LPS et al. (ntl) |
| Dec 31, 2020 | 7 | Motion for Leave to Appear Pro Hac Vice (17) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew) |
| Nov 12, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Nov 9, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (mal) |
| Nov 6, 2020 | 1 | Main Document (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Prinston Pharmaceutical Inc., Solco Healthcare US, LLC, Zhejiang Huahai Pharmaceutical Co., Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3316562.) - filed by Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(mal) |
| Nov 6, 2020 | 1 | Exhibit A-B (60) |
| Nov 6, 2020 | 1 | Civil Cover Sheet (5) |
| Nov 6, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Nov 6, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/28/2020. Date of Expiration of the RE'059 Patent: 04/12/2026; pending Patent Term Extension request, when granted, extends to 12/23/2028.Thirty Month Stay Deadline: 1/10/2023. (mal) |
| Nov 6, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (mal) |
| Nov 6, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co. Ltd. filed by Otsuka Pharmaceutical Co. Ltd.. (mal) |
| Nov 6, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (mal) |
| Nov 6, 2020 | 1 | Complaint* (1) |
